Description:NebuSelect™ Recombinant Human SLAMF7/CRACC/CD319, hFc-tag(Cat#NBL-242085) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Ser23-Met226.

Species:Human

Expression System:HEK293

Molecular Weight: The protein has a predicted MW of 49.2 kDa. Due to glycosylation, the protein migrates to 68-80 kDa based on Bis-Tris PAGE result.

Target Name:SLAMF7/CRACC/CD319SynonymsCD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12

Target Information:CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.

Amino Acid Sequence: Ser23-Met226

Purity:＞95%

Endotoxin:＜1EU/ug(LAL Method)